Pulmonary Disease Doctors in Port St Lucie, FL Accepting Medicare

5 Pulmonary Disease doctors found. Showing 1 - 5

Jose Roberto Castaneda, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1651 Se Tiffany Ave, Port St Lucie, FL 34952 Phone: 772-398-1800    Fax: 772-398-1815

Vivek Kaul, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1651 Se Tiffany Ave, Port St Lucie, FL 34952 Phone: 772-398-1800    Fax: 772-398-1815

Barrington L Nelson M D, Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1801 Se Hillmoor Dr, Ste C103, Port St Lucie, FL 34952 Phone: 772-398-7110    Fax: 772-337-4465

Bharat Upadhyay, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 Se Hillmoor Dr, Suite 200, Port St Lucie, FL 34952 Phone: 772-335-9600    Fax: 772-398-7951

Rose Paccione, Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1651 Se Tiffany Ave, Port St Lucie, FL 34952 Phone: 772-398-1800    Fax: 772-398-1815

News Archive

Gay doctors and patients in the UK fear discrimination

A new report by the British Medical Association (BMA) says that gay and lesbian patients are often reluctant to reveal their sexuality to their doctors because they fear their treatment will suffer.

Scientists join forces to identify a new approach to fight African sleeping sickness

Scientists working in a range of disciplines joined forces to identify a new approach to combat African sleeping sickness. Fundamental research undertaken under the supervision of Professor Ute Hellmich of Johannes Gutenberg University Mainz has revealed a promising strategy to develop a suitable agent.

Researchers report a novel approach to generate T-cells faster

Adoptively transferred T-cells can prolong survival and sometimes cure patients with advanced solid tumors. While promising, it can take months to generate the necessary T-cells to help these patients. Such slow speed makes this therapy impractical for most patients who need immediate treatment.

Positive results from Vertex VX-770 Phase 3 STRIVE study in patients with CF

Vertex Pharmaceuticals Incorporated today announced positive results from the Phase 3 STRIVE study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.

Celmatix presents six research findings at ASRM's annual meeting

Celmatix, a biotechnology company focused on helping physicians guide patients to treatments that maximize their personal reproductive potential, announced today six research presentations at the annual meeting of the American Society for Reproductive Medicine, being held October 12-17 in Boston.

Read more Medical News

› Verified 6 days ago